Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HARRY M COLETTA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1639175219
CMS profile
119182
Location
WALNUT COVE, NC

General Payments · PY2018–2024

$4,037.28

  • Reported across 238 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$634.74

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $634.74 32

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $207.30 8
Boehringer Ingelheim Pharmaceuticals, Inc. $111.42 6
Lilly USA, LLC $72.22 4
GlaxoSmithKline, LLC. $54.14 3
Bayer HealthCare Pharmaceuticals Inc. $45.55 3
Novo Nordisk AS $41.71 2
ABBVIE INC. $32.41 2
Mylan Specialty L.P. $22.22 1
Amgen Inc. $18.11 1
DEXCOM, INC. $16.29 1
PFIZER INC. $13.37 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $400.50 22
PY2019 $626.50 37
PY2020 $350.14 24
PY2021 $889.68 56
PY2022 $614.63 40
PY2023 $521.09 27
PY2024 $634.74 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.67 01/30/2024 Food and Beverage Undisputed 01/23/2026 1103490561 CMS
ABBVIE INC. $15.74 08/23/2024 Food and Beverage Undisputed 01/23/2026 1103490563 CMS
Amgen Inc. $18.11 05/07/2024 Food and Beverage Undisputed 01/23/2026 1117227124 CMS
AstraZeneca Pharmaceuticals LP $68.65 01/09/2024 Food and Beverage Undisputed 01/23/2026 1105377237 CMS
AstraZeneca Pharmaceuticals LP $15.63 01/19/2024 Food and Beverage Undisputed 01/23/2026 1105456194 CMS
AstraZeneca Pharmaceuticals LP $23.19 02/16/2024 Food and Beverage Undisputed 01/23/2026 1105722122 CMS
AstraZeneca Pharmaceuticals LP $20.79 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104730039 CMS
AstraZeneca Pharmaceuticals LP $16.55 05/16/2024 Food and Beverage Undisputed 01/23/2026 1105248936 CMS
AstraZeneca Pharmaceuticals LP $21.74 07/11/2024 Food and Beverage Undisputed 01/23/2026 1105503928 CMS
AstraZeneca Pharmaceuticals LP $18.00 07/25/2024 Food and Beverage Undisputed 01/23/2026 1104764018 CMS
AstraZeneca Pharmaceuticals LP $22.75 11/08/2024 Food and Beverage Undisputed 01/23/2026 1105445965 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.44 03/15/2024 Food and Beverage Undisputed 01/23/2026 1086127516 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.88 08/15/2024 Food and Beverage Undisputed 01/23/2026 1086189270 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.23 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086115184 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.11 02/20/2024 Food and Beverage Undisputed 01/23/2026 1118089412 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.25 04/09/2024 Food and Beverage Undisputed 01/23/2026 1118089418 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.25 05/30/2024 Food and Beverage Undisputed 01/23/2026 1118089414 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.81 07/09/2024 Food and Beverage Undisputed 01/23/2026 1118089408 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 08/13/2024 Food and Beverage Undisputed 01/23/2026 1118089416 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.00 10/25/2024 Food and Beverage Undisputed 01/23/2026 1118089410 CMS
Dexcom, Inc. $16.29 05/02/2024 Food and Beverage Undisputed 01/23/2026 1153303171 CMS
GlaxoSmithKline, LLC. $15.14 05/09/2024 Food and Beverage Undisputed 01/23/2026 1115909136 CMS
GlaxoSmithKline, LLC. $15.56 09/27/2024 Food and Beverage Undisputed 01/23/2026 1116420699 CMS
GlaxoSmithKline, LLC. $23.44 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116316780 CMS
Lilly USA, LLC $22.77 02/06/2024 Food and Beverage Undisputed 01/23/2026 1135014725 CMS
Lilly USA, LLC $13.23 07/18/2024 Food and Beverage Undisputed 01/23/2026 1134997056 CMS
Lilly USA, LLC $14.13 08/08/2024 Food and Beverage Undisputed 01/23/2026 1134979826 CMS
Lilly USA, LLC $22.09 09/17/2024 Food and Beverage Undisputed 01/23/2026 1135014507 CMS
Mylan Specialty L.P. $22.22 03/21/2024 Food and Beverage Undisputed 01/23/2026 1147339209 CMS
Novo Nordisk Inc $20.19 05/21/2024 Food and Beverage Undisputed 01/23/2026 1097807105 CMS
Novo Nordisk Inc $21.52 11/14/2024 Food and Beverage Undisputed 01/23/2026 1097317526 CMS
PFIZER INC. $13.37 01/18/2024 Food and Beverage Undisputed 01/23/2026 1131095478 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.